biorepository

Investigators aim to enroll 3,500 patients into the prospective, observational study, which is supported by multiple drugmakers.

Researchers found that the data in the repository as of 2021 wasn't adequately representative of some racial and ethnic groups, but AACR is actively trying to address this disparity.

Under a five-year MoU, the organizations will conduct research to advance medical applications for breast and lung cancer as well as in other settings such as cardiac and kidney disease.